William J. Taylor

William J. Taylor

Auto-generated profile, based on publicly available information

William J. Taylor

University of Otago Wellington Wellington New Zealand

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in The Lancet
Verified
Journal Article
Closed access
CMChristopher J L Murray
Christopher J L Murray
TVTheo Vos
Theo Vos
RLRafael Lozano
Rafael Lozano
MNMohsen Naghavi
Mohsen Naghavi
AFAbraham D Flaxman
Abraham D Flaxman
ALAlan D Lopez
Alan D Lopez

26 July 2006 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
WTWilliam Taylor
William Taylor
DGDafna Gladman
Dafna Gladman
PHPhilip Helliwell
Philip Helliwell
AMAntonio Marchesoni
Antonio Marchesoni
PMPhilip Mease
Philip Mease
HMHerman Mielants
Herman Mielants
Objective: To compare the accuracy of existing classification criteria for the diagnosis of psoriatic arthritis (PsA) and to construct new criteria from observed data.Methods: Data were collected prospectively from consecutive clinic attendees with PsA and other inflammatory arthropathies. Subjects were classified by each of 7 criteria. Sensitivity and specificity were compared using conditional logistic regression analysis. Latent class analysis was used to calculate criteria accuracy in order to confirm the validity of clinical diagnosis as the gold standard definition of “case”‐ness. Classification and Regression Trees methodology and logistic regression were used to identify items for new criteria, which were then constructed using a receiver operating characteristic curve.Results: Data were collected on 588 cases and 536 controls with rheumatoid arthritis (n = 384), ankylosing spondylitis (n = 72), undifferentiated arthritis (n = 38), connective tissue disorders (n = 14), and other diseases (n = 28). The specificity of each set of criteria was high. The sensitivity of the Vasey and Espinoza method (0.97) was similar to that of the method of McGonagle et al (0.98) and greater than that of the methods of Bennett (0.44), Moll and Wright (0.91), the European Spondylarthropathy Study Group (0.74), and Gladman et al (0.91). The CASPAR (ClASsification criteria for Psoriatic ARthritis) criteria consisted of established inflammatory articular disease with at least 3 points from the following features: current psoriasis (assigned a score of 2; all other features were assigned a score of 1), a history of psoriasis (unless current psoriasis was present), a family history of psoriasis (unless current psoriasis was present or there was a history of psoriasis), dactylitis, juxtaarticular new bone formation, rheumatoid factor negativity, and nail dystrophy. These criteria were more specific (0.987 versus 0.960) but less sensitive (0.914 versus 0.972) than those of Vasey and Espinoza.Conclusion: The CASPAR criteria are simple and highly specific but less sensitive than the Vasey and Espinoza criteria.

28 September 2012 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
DKDinesh Khanna
Dinesh Khanna
John FitzGeraldJohn FitzGerald
John FitzGerald
PKPuja Khanna
Puja Khanna
SBSangmee Bae
Sangmee Bae
MSManjit K. Singh
Manjit K. Singh
RTRobert Terkeltaub
Robert Terkeltaub
Click on the article title to read more.

28 September 2012 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
DKDinesh Khanna
Dinesh Khanna
PKPuja Khanna
Puja Khanna
John FitzGeraldJohn FitzGerald
John FitzGerald
MSManjit K. Singh
Manjit K. Singh
SBSangmee Bae
Sangmee Bae
RTRobert Terkeltaub
Robert Terkeltaub
Click on the article title to read more.

16 March 2015 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
WTWilliam J. Taylor
William J. Taylor
JFJaap Fransen
Jaap Fransen
TJTim L. Jansen
Tim L. Jansen
NDNicola Dalbeth
Nicola Dalbeth
HSH. Ralph Schumacher
H. Ralph Schumacher
TNTuhina Neogi
Tuhina Neogi
Objective: To determine which clinical, laboratory, and imaging features most accurately distinguished gout from non‐gout.Methods: We performed a cross‐sectional study of consecutive rheumatology clinic patients with ≥1 swollen joint or subcutaneous tophus. Gout was defined by synovial fluid or tophus aspirate microscopy by certified examiners in all patients. The sample was randomly divided into a model development (two‐thirds) and test sample (one‐third). Univariate and multivariate association between clinical features and monosodium urate–defined gout was determined using logistic regression modeling. Shrinkage of regression weights was performed to prevent overfitting of the final model. Latent class analysis was conducted to identify patterns of joint involvement.Results: In total, 983 patients were included. Gout was present in 509 (52%). In the development sample (n = 653), the following features were selected for the final model: joint erythema (multivariate odds ratio [OR] 2.13), difficulty walking (multivariate OR 7.34), time to maximal pain 6 mg/dl (0.36 mmoles/liter; multivariate OR 3.35), ultrasound double contour sign (multivariate OR 7.23), and radiograph erosion or cyst (multivariate OR 2.49). The final model performed adequately in the test set, with no evidence of misfit, high discrimination, and predictive ability. MTP1 joint involvement was the most common joint pattern (39.4%) in gout cases.Conclusion: Ten key discriminating features have been identified for further evaluation for new gout classification criteria. Ultrasound findings and degree of uricemia add discriminating value, and will significantly contribute to more accurate classification criteria.

1 October 2015 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
AOAlexis Ogdie
Alexis Ogdie
WTWilliam J Taylor
William J Taylor
MWMark Weatherall
Mark Weatherall
JFJaap Fransen
Jaap Fransen
TJTim L Jansen
Tim L Jansen
NDNicola Dalbeth
Nicola Dalbeth
Background Although there has been major progress in gout imaging, no gout classification criteria currently include advanced imaging techniques. Objective To examine the usefulness of imaging modalities in the classification of gout when compared to monosodium urate (MSU) crystal confirmation as the gold standard, in order to inform development of new gout classification criteria. Methods We systematically reviewed the published literature concerning the diagnostic performance of plain film radiography, MRI, ultrasound (US), conventional CT and dual energy CT (DECT). Only studies with MSU crystal confirmation as the gold standard were included. When more than one study examined the same imaging feature, the data were pooled and summary test characteristics were calculated. Results 11 studies (9 manuscripts and 2 meeting abstracts) satisfied the inclusion criteria. All were set in secondary care, with mean gout disease duration of at least 7 years. Three features were examined in more than one study: the double contour sign (DCS) on US, tophus on US, and MSU crystal deposition on DECT. The pooled (95% CI) sensitivity and specificity of US DCS were 0.83 (0.72 to 0.91) and 0.76 (0.68 to 0.83), respectively; of US tophus, were 0.65 (0.34 to 0.87) and 0.80 (0.38 to 0.96), respectively; and of DECT, were 0.87 (0.79 to 0.93) and 0.84 (0.75 to 0.90), respectively. Conclusions US and DECT show promise for gout classification but the few studies to date have mostly been in patients with longstanding, established disease. The contribution of imaging over clinical features for gout classification criteria requires further examination.